Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors.
Heath EI, O'Reilly S, Humphrey R, Sundaresan P, Donehower RC, Sartorius S, Kennedy MJ, Armstrong DK, Carducci MA, Sorensen JM, Kumor K, Kennedy S, Grochow LB.
Heath EI, et al. Among authors: armstrong dk.
Cancer Chemother Pharmacol. 2001 Oct;48(4):269-74. doi: 10.1007/s002800100330.
Cancer Chemother Pharmacol. 2001.
PMID: 11710626
Clinical Trial.